+

WO2009036753A3 - Nouveaux produits pharmaceutiques, procédés de fabrication de ceux-ci et utilisation de ceux-ci en thérapie médicale - Google Patents

Nouveaux produits pharmaceutiques, procédés de fabrication de ceux-ci et utilisation de ceux-ci en thérapie médicale Download PDF

Info

Publication number
WO2009036753A3
WO2009036753A3 PCT/DE2008/001566 DE2008001566W WO2009036753A3 WO 2009036753 A3 WO2009036753 A3 WO 2009036753A3 DE 2008001566 W DE2008001566 W DE 2008001566W WO 2009036753 A3 WO2009036753 A3 WO 2009036753A3
Authority
WO
WIPO (PCT)
Prior art keywords
production
medical therapy
novel pharmaceuticals
novel
pharmaceuticals
Prior art date
Application number
PCT/DE2008/001566
Other languages
German (de)
English (en)
Other versions
WO2009036753A2 (fr
Inventor
Hans Scheefers
Original Assignee
Schebo Biotech Ag
Hans Scheefers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schebo Biotech Ag, Hans Scheefers filed Critical Schebo Biotech Ag
Publication of WO2009036753A2 publication Critical patent/WO2009036753A2/fr
Publication of WO2009036753A3 publication Critical patent/WO2009036753A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouveaux produits pharmaceutiques à base de nouvelles 4-pyridine-3yl-pyrimidines substituées, des procédés de fabrication de ceux-ci, ainsi que leur utilisation en thérapie médicale, notamment en cas de maladies cancéreuses.
PCT/DE2008/001566 2007-09-20 2008-09-19 Nouveaux produits pharmaceutiques, procédés de fabrication de ceux-ci et utilisation de ceux-ci en thérapie médicale WO2009036753A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007046266 2007-09-20
DE102007046266.4 2007-09-20

Publications (2)

Publication Number Publication Date
WO2009036753A2 WO2009036753A2 (fr) 2009-03-26
WO2009036753A3 true WO2009036753A3 (fr) 2009-05-07

Family

ID=40379649

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2008/001566 WO2009036753A2 (fr) 2007-09-20 2008-09-19 Nouveaux produits pharmaceutiques, procédés de fabrication de ceux-ci et utilisation de ceux-ci en thérapie médicale

Country Status (1)

Country Link
WO (1) WO2009036753A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009019852A1 (de) 2009-05-06 2010-11-11 Schebo Biotech Ag Polymere mit neuen Strukturelementen, Verfahren zu ihrer Herstellung und ihre Verwendung

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224967A1 (en) * 2003-05-02 2004-11-11 Chen Guoqing P Phenylaminopyrimidine derivatives and methods of use
US20040248918A1 (en) * 2003-05-06 2004-12-09 Il Yang Pharm. Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
WO2005058320A1 (fr) * 2003-12-19 2005-06-30 Novartis Ag Combinaison de (a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine et (b) au moins un inhibiteur de formation de l'hypusine et son utilisation
WO2005075454A2 (fr) * 2004-02-04 2005-08-18 Novartis Ag Formes salines de 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
WO2006021458A2 (fr) * 2004-08-27 2006-03-02 Gpc Biotech Ag Derives de pyrimidine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224967A1 (en) * 2003-05-02 2004-11-11 Chen Guoqing P Phenylaminopyrimidine derivatives and methods of use
US20040248918A1 (en) * 2003-05-06 2004-12-09 Il Yang Pharm. Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
WO2005058320A1 (fr) * 2003-12-19 2005-06-30 Novartis Ag Combinaison de (a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine et (b) au moins un inhibiteur de formation de l'hypusine et son utilisation
WO2005075454A2 (fr) * 2004-02-04 2005-08-18 Novartis Ag Formes salines de 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
WO2006021458A2 (fr) * 2004-08-27 2006-03-02 Gpc Biotech Ag Derives de pyrimidine

Also Published As

Publication number Publication date
WO2009036753A2 (fr) 2009-03-26

Similar Documents

Publication Publication Date Title
WO2009068214A3 (fr) Pipéridines à substitution hétéroaryl
EP2054416B8 (fr) Pyrazolopyrimidines substituées, procédé de préparation et d'utilisation de celles-ci en tant que médicaments
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
ZA201001015B (en) (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
IL204556A0 (en) (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
IL203496A (en) Pharmaceutical products - improved coating, production and use
IL176913A0 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
WO2008046581A3 (fr) Composés tétrahydropyrrolopyrazine substitués et leur utilisation dans des médicaments
IL185804A0 (en) Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
WO2008089397A3 (fr) Marqueurs du cancer adrb2
WO2008054585A3 (fr) Utilisation d'il-10 pégilée pour traiter un cancer
ZA200805939B (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
WO2010078900A3 (fr) Nouvelles pyrazolopyridines à substitution aliphatique et leur utilisation
IL195245A0 (en) Substituted prolinamides, production thereof and their use as drugs
HRP20130558T1 (hr) Derivat 17-hidroksi-17-pentafluoretil-estra-4,9(10)-dien-11-arila, postupci za njegovu proizvodnju i njegova uporaba za lijeäśenje bolesti
WO2009071690A3 (fr) Dérivés d'oxindole à double substitution en positions 5 et 6 et leur utilisation pour traiter des maladies liées à la vasopressine
IL193341A0 (en) Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
IL193339A0 (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
WO2010077589A3 (fr) Inhibiteurs de stat3 et méthodes thérapeutiques les utilisant
WO2009115252A3 (fr) Pyrazolamides substitués et leur utilisation
PT2225314T (pt) Silicones-autoadesivos, método de fabrico, complexos que os utilizam e aplicações
WO2007140804A8 (fr) Procédé de préparation d'un oxaliplatine
WO2008110374A3 (fr) Granulés contenant une substance pharmaceutique, procédés de fabrication et utilisation de ceux-ci
PL1718340T3 (pl) Nowe koniugaty efektorowe, sposób ich wytwarzania i ich zastosowanie farmaceutyczne
SG148120A1 (en) An oral pharmaceutical and an oral care product

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08831840

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08831840

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载